Christoph Scharf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christoph Scharf has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Lam Dang
Cardiovascular Center, Clinic im Park, Zurich, Switzerland
7 shared publicationsBarbara Naegeli
Cardiovascular Center, Clinic im Park, Zurich, Switzerland
2 shared publicationsChristine H. Attenhofer Jost
Cardiovascular Center, Clinic im Park, Zurich, Switzerland
2 shared publications- Firat Duru
Department of Cardiology, University Hospital Zurich, Zurich, Switzerland
2 shared publications Fred Morady
2 shared publicationsGabor Sütsch
Cardiovascular Center, Clinic im Park, Seestrasse 220, 8027 Zurich, Switzerland
2 shared publications
Latest Publications
- 21 March 2019
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (6)
High-resolution noncontact charge-density mapping of endocardial activation
BACKGROUND. Spatial resolution in cardiac activation maps based on voltage measurement is limited by far-field interference. Precise characterization of electrical sources would resolve this limitation; however, practical charge-based cardiac mapping has not been achieved. METHODS. A prototype algorithm, developed from first principles of electrostatic field theory, derives charge density (CD) as a spatial representation of the true sources of the cardiac field. The algorithm processes multiple, simultaneous, noncontact voltage measurements within the cardiac chamber to inversely derive the global distribution of CD sources across the endocardial surface. RESULTS. Comparison of CD to an established computer-simulated model of atrial conduction demonstrated feasibility in terms of spatial, temporal, and morphologic metrics. Inverse reconstruction matched simulation with median spatial errors of 1.73 mm and 2.41 mm for CD and voltage, respectively. Median temporal error was less than 0.96 ms and morphologic correlation was greater than 0.90 for both CD and voltage. Activation patterns observed in human atrial flutter reproduced those established through contact maps, with a 4-fold improvement in resolution noted for CD over voltage. Global activation maps (charge density–based) are reported in atrial fibrillation with confirmed reduction of far-field interference. Arrhythmia cycle-length slowing and termination achieved through ablation of critical points demonstrated in the maps indicates both mechanistic and pathophysiological relevance. CONCLUSION. Global maps of cardiac activation based on CD enable classification of conduction patterns and localized nonpulmonary vein therapeutic targets in atrial fibrillation. The measurement capabilities of the approach have roles spanning deep phenotyping to therapeutic application. TRIAL REGISTRATION. ClinicalTrials.gov NCT01875614. FUNDING. The National Institute for Health Research (NIHR) Translational Research Program at Royal Papworth Hospital and Acutus Medical.
- 21 March 2019
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (6)
High-resolution noncontact charge-density mapping of endocardial activation
BACKGROUND. Spatial resolution in cardiac activation maps based on voltage measurement is limited by far-field interference. Precise characterization of electrical sources would resolve this limitation; however, practical charge-based cardiac mapping has not been achieved. METHODS. A prototype algorithm, developed from first principles of electrostatic field theory, derives charge density (CD) as a spatial representation of the true sources of the cardiac field. The algorithm processes multiple, simultaneous, noncontact voltage measurements within the cardiac chamber to inversely derive the global distribution of CD sources across the endocardial surface. RESULTS. Comparison of CD to an established computer-simulated model of atrial conduction demonstrated feasibility in terms of spatial, temporal, and morphologic metrics. Inverse reconstruction matched simulation with median spatial errors of 1.73 mm and 2.41 mm for CD and voltage, respectively. Median temporal error was less than 0.96 ms and morphologic correlation was greater than 0.90 for both CD and voltage. Activation patterns observed in human atrial flutter reproduced those established through contact maps, with a 4-fold improvement in resolution noted for CD over voltage. Global activation maps (charge density–based) are reported in atrial fibrillation with confirmed reduction of far-field interference. Arrhythmia cycle-length slowing and termination achieved through ablation of critical points demonstrated in the maps indicates both mechanistic and pathophysiological relevance. CONCLUSION. Global maps of cardiac activation based on CD enable classification of conduction patterns and localized nonpulmonary vein therapeutic targets in atrial fibrillation. The measurement capabilities of the approach have roles spanning deep phenotyping to therapeutic application. TRIAL REGISTRATION. ClinicalTrials.gov NCT01875614. FUNDING. The National Institute for Health Research (NIHR) Translational Research Program at Royal Papworth Hospital and Acutus Medical.
- 1 June 2018
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 4 (6) , 842-843
Coronary Occlusion to Avoid Heat Convection During Radiofrequency Ablation of an Accessory Pathway
- 1 June 2018
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 4 (6) , 842-843
Coronary Occlusion to Avoid Heat Convection During Radiofrequency Ablation of an Accessory Pathway
- Open Access
- 31 May 2016
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 18 (8) , 1164-1169
Safety and efficacy of the nMARQ catheter for paroxysmal and persistent atrial fibrillation
Circular irrigated radiofrequency ablation using the nMARQ catheter has recently been introduced for the treatment of atrial fibrillation (AF). The aim of this study is to report the safety and efficacy of catheter ablation using this technology in patients with paroxysmal and persistent AF. The data of a prospective registry describing the experience of a single operator using this technology on 327 consecutive patients were analysed. The mean procedure time was 69 ± 22 min for paroxysmal AF (n = 228) and 75 ± 23 min for persistent AF (n = 97). Follow-up was available for 206 (63%) patients for 6 ± 5 months (range 1–23, median 3.3). Single procedure success off antiarrhythmic drugs was 75% in paroxysmal AF and 52% in persistent AF. Including the 5% redo cases and those on antiarrhythmic medication, freedom from AF was documented in 90 and 83% of paroxysmal and persistent AF patients, respectively. There were no serious complications in the first 325 patients, but the last two consecutive patients (0.6%) developed atrio-oesophageal fistulas and had a fatal outcome. The catheter has been recalled from market. The nMARQ catheter is a highly effective tool for treatment of paroxysmal and persistent AF. Nevertheless, the occurrence of life-threatening oesophageal fistulas is of major concern and requires further investigation.
- 31 May 2016
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 18 (8) , 1164-1169
Open AccessSafety and efficacy of the nMARQ catheter for paroxysmal and persistent atrial fibrillation
Circular irrigated radiofrequency ablation using the nMARQ catheter has recently been introduced for the treatment of atrial fibrillation (AF). The aim of this study is to report the safety and efficacy of catheter ablation using this technology in patients with paroxysmal and persistent AF. The data of a prospective registry describing the experience of a single operator using this technology on 327 consecutive patients were analysed. The mean procedure time was 69 ± 22 min for paroxysmal AF (n = 228) and 75 ± 23 min for persistent AF (n = 97). Follow-up was available for 206 (63%) patients for 6 ± 5 months (range 1–23, median 3.3). Single procedure success off antiarrhythmic drugs was 75% in paroxysmal AF and 52% in persistent AF. Including the 5% redo cases and those on antiarrhythmic medication, freedom from AF was documented in 90 and 83% of paroxysmal and persistent AF patients, respectively. There were no serious complications in the first 325 patients, but the last two consecutive patients (0.6%) developed atrio-oesophageal fistulas and had a fatal outcome. The catheter has been recalled from market. The nMARQ catheter is a highly effective tool for treatment of paroxysmal and persistent AF. Nevertheless, the occurrence of life-threatening oesophageal fistulas is of major concern and requires further investigation.
- Open Access
- 25 July 2013
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (35) , 2738
Epicardial Wolff–Parkinson–White ablation
A 45-year-old female patient without structural heart disease was referred for redo Wolff–Parkinson–White (WPW) ablation after an unsuccessful endocardial procedure. The refractory period of the accessory pathway had been measured at 230 ms and antiarrhythmic treatment with flecainide was unsuccessful. Epicardial access can be necessary, if the largest negative δ-wave is in lead III on the surface ECG. The morphology of the unipolar signal indicates the true epicardial origin of the ventricular pathway insertion. Success can be observed even after delayed response to RF delivery.
- 25 July 2013
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 34 (35) , 2738
Open AccessEpicardial Wolff–Parkinson–White ablation
A 45-year-old female patient without structural heart disease was referred for redo Wolff–Parkinson–White (WPW) ablation after an unsuccessful endocardial procedure. The refractory period of the accessory pathway had been measured at 230 ms and antiarrhythmic treatment with flecainide was unsuccessful. Epicardial access can be necessary, if the largest negative δ-wave is in lead III on the surface ECG. The morphology of the unipolar signal indicates the true epicardial origin of the ventricular pathway insertion. Success can be observed even after delayed response to RF delivery.
- Open Access
- 8 August 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (8) , e19914
Electrical Activation in the Coronary Sinus Branches as a Guide to Cardiac Resynchronisation Therapy: Rationale for a Coordinate System
For successful cardiac resynchronisation therapy (CRT) a spatial and electrical separation of right and left ventricular electrodes is essential. The spatial distribution of electrical delays within the coronary sinus (CS) tributaries has not yet been identified. Electrical delays within the CS are described during sinus rhythm (SR) and right ventricular pacing (RVP). A coordinate system grading the mitral ring from 0° to 360° and three vertical segments is proposed to define the lead positions irrespective of individual CS branch orientation. In 13 patients undergoing implantation of a CRT device 6±2.5, (median 5) lead positions within the CS were mapped during SR and RVP. The delay to the onset and the peak of the local signal was measured from the earliest QRS activation or the pacing spike. Fluoroscopic positions were compared to localizations on a nonfluoroscopic electrode imaging system. During SR, electrical delays in the CS were inhomogenous in patients with or without left bundle branch block (LBBB). During RVP, the delays increased by 44±32 ms (signal onset from 36±33 ms to 95±30 ms; p2, p<0.0001. This indicates that 78% of the QRS duration can be expected as a maximum peak delay at 162° on the CS ring. Electrical delays within the CS vary during SR, but prolong and become predictable during RVP. A coordinate system helps predicting the local delays and facilitates interindividual comparison of lead positions irrespective of CS branch anatomy.
- 8 August 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (8) , e19914
Open AccessElectrical Activation in the Coronary Sinus Branches as a Guide to Cardiac Resynchronisation Therapy: Rationale for a Coordinate System
For successful cardiac resynchronisation therapy (CRT) a spatial and electrical separation of right and left ventricular electrodes is essential. The spatial distribution of electrical delays within the coronary sinus (CS) tributaries has not yet been identified. Electrical delays within the CS are described during sinus rhythm (SR) and right ventricular pacing (RVP). A coordinate system grading the mitral ring from 0° to 360° and three vertical segments is proposed to define the lead positions irrespective of individual CS branch orientation. In 13 patients undergoing implantation of a CRT device 6±2.5, (median 5) lead positions within the CS were mapped during SR and RVP. The delay to the onset and the peak of the local signal was measured from the earliest QRS activation or the pacing spike. Fluoroscopic positions were compared to localizations on a nonfluoroscopic electrode imaging system. During SR, electrical delays in the CS were inhomogenous in patients with or without left bundle branch block (LBBB). During RVP, the delays increased by 44±32 ms (signal onset from 36±33 ms to 95±30 ms; p2, p<0.0001. This indicates that 78% of the QRS duration can be expected as a maximum peak delay at 162° on the CS ring. Electrical delays within the CS vary during SR, but prolong and become predictable during RVP. A coordinate system helps predicting the local delays and facilitates interindividual comparison of lead positions irrespective of CS branch anatomy.
- 29 April 2011
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 34 (9) , 1128-1137
Initial Results of Linear Duty‐Cycled Radiofrequency for Atypical Flutter and Atrial Tachycardia
Background: Duty‐cycled radiofrequency (DCRF) is increasingly used for ablation of atrial fibrillation (AF). Many patients also have atrial flutter (AFL). Recently, a linear multielectrode has been shown to create linear block at the cavotricuspid isthmus and in the left atrium (LA). Objective: To map and ablate atypical AFL and atrial tachycardias (ATs) in the right and LA using a linear multielectrode with DCRF. Methods: The linear multielectrode delivers DCRF at 20–45 W maximum in 1:1 unipolar/bipolar temperature‐controlled mode. Target temperatures were manually titrated to 60 °C in the LA, if power >5W indicated adequate passive cooling. Results: A total of 76 AT/AFL were targeted in 57 patients. Acute success was reached in 14/15 (93%) right AT, in 17/22 (77%) left atrial roof AFL, in 5/6 (83%) septal AFL, in 9/9 (100%) other left atrial AT, but only in 8/23 (35%) AFL from the mitral isthmus (which rose to 13/23 [57%] with additional use of irrigated radiofrequency). Nevertheless, freedom of AF/AFL 10 ± 6 months after a single procedure was documented in 92% of right AT, 71% of roof AFL, 73% for mitral AFL, and 60% of septal or other LA AT/AFL. No char formation was noted. However, frequent induction of AF and one case of asystole occurred during delivery of DCRF in a pacemaker patient. Conclusion: The linear multielectrode allows mapping and ablation of atypical AFL/AT. Freedom of AF/AT was reached in 60%–92% depending on localization and number of arrhythmias. Technical modifications will improve safety and efficacy. (PACE 2011; 34:1128–1137)
- 29 April 2011
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 34 (9) , 1128-1137
Initial Results of Linear Duty‐Cycled Radiofrequency for Atypical Flutter and Atrial Tachycardia
Background: Duty‐cycled radiofrequency (DCRF) is increasingly used for ablation of atrial fibrillation (AF). Many patients also have atrial flutter (AFL). Recently, a linear multielectrode has been shown to create linear block at the cavotricuspid isthmus and in the left atrium (LA). Objective: To map and ablate atypical AFL and atrial tachycardias (ATs) in the right and LA using a linear multielectrode with DCRF. Methods: The linear multielectrode delivers DCRF at 20–45 W maximum in 1:1 unipolar/bipolar temperature‐controlled mode. Target temperatures were manually titrated to 60 °C in the LA, if power >5W indicated adequate passive cooling. Results: A total of 76 AT/AFL were targeted in 57 patients. Acute success was reached in 14/15 (93%) right AT, in 17/22 (77%) left atrial roof AFL, in 5/6 (83%) septal AFL, in 9/9 (100%) other left atrial AT, but only in 8/23 (35%) AFL from the mitral isthmus (which rose to 13/23 [57%] with additional use of irrigated radiofrequency). Nevertheless, freedom of AF/AFL 10 ± 6 months after a single procedure was documented in 92% of right AT, 71% of roof AFL, 73% for mitral AFL, and 60% of septal or other LA AT/AFL. No char formation was noted. However, frequent induction of AF and one case of asystole occurred during delivery of DCRF in a pacemaker patient. Conclusion: The linear multielectrode allows mapping and ablation of atypical AFL/AT. Freedom of AF/AT was reached in 60%–92% depending on localization and number of arrhythmias. Technical modifications will improve safety and efficacy. (PACE 2011; 34:1128–1137)
- Open Access
Electrophysiology of living organs from first principles
Based on the derivation of the macroscopic Maxwell's equations by spatial averaging of the microscopic equations, we discuss the electrophysiology of living organs. Other methods of averaging (or homogenization) like the bidomain model are not compatible with Maxwell's theory. We also point out that modeling the active cells by source currents is not a suitable description of the situation from first principles. Instead, it turns out that the main source of the measured electrical potentials is the polarization charge density which exists at the membranes of the active cells and adds up to a macroscopic polarization. The latter is the source term in the Laplace equation, the solution of which gives the measured far-field potential. As a consequence it is the polarization or dipole density which is best suited for localization of cardiac arrhythmia.
Open AccessElectrophysiology of living organs from first principles
Based on the derivation of the macroscopic Maxwell's equations by spatial averaging of the microscopic equations, we discuss the electrophysiology of living organs. Other methods of averaging (or homogenization) like the bidomain model are not compatible with Maxwell's theory. We also point out that modeling the active cells by source currents is not a suitable description of the situation from first principles. Instead, it turns out that the main source of the measured electrical potentials is the polarization charge density which exists at the membranes of the active cells and adds up to a macroscopic polarization. The latter is the source term in the Laplace equation, the solution of which gives the measured far-field potential. As a consequence it is the polarization or dipole density which is best suited for localization of cardiac arrhythmia.
- 1 April 2010
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 33 (4) , 444-450
Linear Ablation with Duty-Cycled Radiofrequency Energy at the Cavotricuspid Isthmus
Multielectrode catheters using duty-cycled radiofrequency (RF) have been developed to treat atrial fibrillation (AF). Many of these patients also have atrial flutter. Therefore, a linear multielectrode has been developed using the same RF energy.The concept and acute results of linear ablation using duty-cycled RF were tested in the cavotricuspid isthmus (CTI).The CTI was targeted in 75 patients, in 68 (90%) among them as an adjunct to AF ablation with the same technology. A linear electrode catheter with a 4-mm tip and five 2-mm ring electrodes was connected to a generator titrating duty-cycled RF at 20-45 W up to a target temperature of 70 degrees C in 1:1 unipolar/bipolar mode.During a mean procedure time of 20 +/- 12 minutes, complete CTI block was achieved by 4 +/- 3 applications of duty-cycled RF in 69 (92%) patients. No more than three RF applications were necessary in 60% of patients. During the initial learning curve, standard RF had to be used in five (7%) patients. Complete block was not achieved in one patient with frequent episodes of AF. Char was observed in five (7%) patients with poor electrode cooling; consequently, the temperature ramp-up was slowed and manually turned off in the event of low-power delivery. Two groin hematomas occurred; otherwise, no clinical complications were observed.Multielectrode catheters delivering duty-cycled RF can effectively ablate the CTI with few RF applications with promising acute results. Further modifications are necessary to improve catheter steering and prevent char formation. (PACE 2010; 444-450).
- 1 April 2010
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 33 (4) , 444-450
Linear Ablation with Duty-Cycled Radiofrequency Energy at the Cavotricuspid Isthmus
Multielectrode catheters using duty-cycled radiofrequency (RF) have been developed to treat atrial fibrillation (AF). Many of these patients also have atrial flutter. Therefore, a linear multielectrode has been developed using the same RF energy.The concept and acute results of linear ablation using duty-cycled RF were tested in the cavotricuspid isthmus (CTI).The CTI was targeted in 75 patients, in 68 (90%) among them as an adjunct to AF ablation with the same technology. A linear electrode catheter with a 4-mm tip and five 2-mm ring electrodes was connected to a generator titrating duty-cycled RF at 20-45 W up to a target temperature of 70 degrees C in 1:1 unipolar/bipolar mode.During a mean procedure time of 20 +/- 12 minutes, complete CTI block was achieved by 4 +/- 3 applications of duty-cycled RF in 69 (92%) patients. No more than three RF applications were necessary in 60% of patients. During the initial learning curve, standard RF had to be used in five (7%) patients. Complete block was not achieved in one patient with frequent episodes of AF. Char was observed in five (7%) patients with poor electrode cooling; consequently, the temperature ramp-up was slowed and manually turned off in the event of low-power delivery. Two groin hematomas occurred; otherwise, no clinical complications were observed.Multielectrode catheters delivering duty-cycled RF can effectively ablate the CTI with few RF applications with promising acute results. Further modifications are necessary to improve catheter steering and prevent char formation. (PACE 2010; 444-450).
- 20 January 2010
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 27 (2) , 89-94
Interaction of vitamin K antagonists with heparin affect monitoring by activated clotting times
Unfractionated heparin is recommended during atrial fibrillation (AF) ablation to achieve activated clotting time (ACT) above 250–300 s to prevent clot. Many patients on therapeutic international normalised ratio (INR) undergo AF ablation procedures; however, it is unknown whether they require less heparin to achieve similar ACT levels. During AF ablation, the ACT was measured before and 10 min after administration of i.v. unfractionated heparin in patients with and without anticoagulation. The association of INR, heparin, pre-procedure ACT and body weight with ACT after heparin administration was tested using multivariable linear regression models. The subjects of this study were 149 patients undergoing AF ablation, among them 40 (27%) with subtherapeutic INR < 2, 79 (53%) with an INR between 2 and 3, and 30 (20%) patients with INR > 3. Baseline ACT was associated with INR (r = 0.33, p < 0.001). After a mean of 8,685 ± 2,015 U (range, 5,000–15,000 IU) unfractionated heparin, univariate predictors of ACT were baseline INR (p < 0.001), heparin dose (p = 0.012) and baseline ACT (p = 0.027). In the multivariable model, baseline INR (part r = 0.64, p < 0.001) and heparin dose (part r = 0.33, p < 0.001) strongly predicted post-heparin ACT. Estimated from the regression model, the heparin dose reductions by approximately one third in those with an INR of 2–3 and by at least two thirds in those with an INR above 3 may be favourable. Over the following 3 months, no thromboembolism and acute bleeding were observed. The INR was the strongest predictor of post-heparin ACT, even more important than the heparin dose itself. The reduction of heparin dose by one third if INR is between 2–3 and by two thirds if INR is above 3 may be favourable.
- 20 January 2010
- Published by Springer Nature in Journal of Interventional Cardiac Electrophysiology
- Vol. 27 (2) , 89-94
Interaction of vitamin K antagonists with heparin affect monitoring by activated clotting times
Unfractionated heparin is recommended during atrial fibrillation (AF) ablation to achieve activated clotting time (ACT) above 250–300 s to prevent clot. Many patients on therapeutic international normalised ratio (INR) undergo AF ablation procedures; however, it is unknown whether they require less heparin to achieve similar ACT levels. During AF ablation, the ACT was measured before and 10 min after administration of i.v. unfractionated heparin in patients with and without anticoagulation. The association of INR, heparin, pre-procedure ACT and body weight with ACT after heparin administration was tested using multivariable linear regression models. The subjects of this study were 149 patients undergoing AF ablation, among them 40 (27%) with subtherapeutic INR < 2, 79 (53%) with an INR between 2 and 3, and 30 (20%) patients with INR > 3. Baseline ACT was associated with INR (r = 0.33, p < 0.001). After a mean of 8,685 ± 2,015 U (range, 5,000–15,000 IU) unfractionated heparin, univariate predictors of ACT were baseline INR (p < 0.001), heparin dose (p = 0.012) and baseline ACT (p = 0.027). In the multivariable model, baseline INR (part r = 0.64, p < 0.001) and heparin dose (part r = 0.33, p < 0.001) strongly predicted post-heparin ACT. Estimated from the regression model, the heparin dose reductions by approximately one third in those with an INR of 2–3 and by at least two thirds in those with an INR above 3 may be favourable. Over the following 3 months, no thromboembolism and acute bleeding were observed. The INR was the strongest predictor of post-heparin ACT, even more important than the heparin dose itself. The reduction of heparin dose by one third if INR is between 2–3 and by two thirds if INR is above 3 may be favourable.